The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
Endogenous diacylglycerol, as produced during ligand-stimulated hydrolysis of phosphatidylinositol, is a physiological activator of protein kinase C, a receptor for the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Diacylglycerol mimics many effects of phorbol ester TPA, but it is not known whether diacylglycerol is a mouse skin tumor promoter. The present studies determined the mouse skin tumor-promoting activity of L-alpha-dioctanoylglycerol (DG), a membrane-permeable diacylglycerol derivative. In two independent experiments with female SENCAR mice, DG at a 2 mumol dose, when applied twice weekly to the initiated mouse skin, failed to promote mouse skin tumor formation. Similarly, DG lacked Stage I tumor-promoting activity; twice weekly applications of DG for 2 wk to the initiated mouse skin followed by twice weekly applications of mezerein (3.3 nmol) for as long as 27 wk elicited only a few papillomas per mouse. DG was found to be a potent Stage II mouse skin tumor promoter. In a typical two-stage tumor promotion experiment, SENCAR mice were initiated by application of 20 nmol of DMBA to their shaved backs. Two wk after initiation, 3.3 nmol of TPA were applied twice weekly for 2 wk (Stage I), and then 2 mumol of DG or 3.3 nmol of mezerein were applied to the skin twice weekly for the entire duration of the experiment (Stage II). Stage II tumor promotion with mezerein and DG resulted in 13.33 +/- 0.88 and 11.13 +/- 1.25 papillomas per mouse, respectively, at 19 wk and the carcinoma incidence, 43% and 33%, respectively, at 27 wk of promotion. The tumor-promoting activity of DG was compared with the parent alcohol glycerol, and it was found that glycerol, at a dose as high as 11 mumol, was not a complete, Stage I or Stage II mouse skin tumor promoter. Both TPA and DG, when applied to mouse skin, induced epidermal ornithine decarboxylase activity. Both TPA and DG activate protein kinase C, but the results presented indicate that TPA and DG differ in their tumor-promoting properties. DG, like mezerein, is a Stage II mouse skin tumor promoter.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D002273:Carcinogens; D004075:Diglycerides / Q000494:pharmacology*; D004224:Diterpenes; D004789:Enzyme Activation; D004790:Enzyme Induction / Q000187:drug effects; D005989:Glycerides / Q000494:pharmacology*; D005990:Glycerol / Q000494:pharmacology; D051379:Mice; D009955:Ornithine Decarboxylase / Q000096:biosynthesis; D011493:Protein Kinase C / Q000378:metabolism*; D012878:Skin Neoplasms / Q000139:chemically induced*; D013729:Terpenes / Q000494:pharmacology
D002273:Carcinogens; D004075:Diglycerides; D004224:Diterpenes; D005989:Glycerides; D013729:Terpenes; C044295:1,2-dioctanoylglycerol; C011309:mezerein; D015127:9,10-Dimethyl-1,2-benzanthracene; D011493:Protein Kinase C; D009955:Ornithine Decarboxylase; D005990:Glycerol